Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation.
about
Mammalian target of rapamycin is a therapeutic target for murine ovarian endometrioid adenocarcinomas with dysregulated Wnt/β-catenin and PTENThe PI3K-Akt-mTOR pathway in initiation and progression of thyroid tumors.Molecular and functional characteristics of ovarian surface epithelial cells transformed by KrasG12D and loss of Pten in a mouse model in vivo.Preservation of tumor-host immune interactions with luciferase-tagged imaging in a murine model of ovarian cancerAn activating Pik3ca mutation coupled with Pten loss is sufficient to initiate ovarian tumorigenesis in mice.Role of phosphatidylinositol-3-kinase pathway in head and neck squamous cell carcinoma.Arid1a inactivation in an Apc- and Pten-defective mouse ovarian cancer model enhances epithelial differentiation and prolongs survival.Technical challenges and limitations of current mouse models of ovarian cancer.PTEN loss and HOXA10 expression are associated with ovarian endometrioid adenocarcinoma differentiation and progression.Type I to type II ovarian carcinoma progression: mutant Trp53 or Pik3ca confers a more aggressive tumor phenotype in a mouse model of ovarian cancer.Evaluating the progenitor cells of ovarian cancer: analysis of current animal models.Modeling High-Grade Serous Carcinoma: How Converging Insights into Pathogenesis and Genetics are Driving Better Experimental Platforms.Ovarian cancer mouse models: a summary of current models and their limitations.
P2860
Q27335766-A6199F35-F77A-43D8-B98D-D757D4671CDEQ33770769-303C6CE9-52D6-46BC-81F4-2BA963C5E7BAQ35116008-DBF2E3DF-73FE-4DD2-B7C6-AE167B378981Q35623804-5A52D835-34F0-4118-A999-B0AFA2DB818AQ35698954-564CE436-D8C4-4937-B0C8-BBF6080B58F5Q35994228-27051E24-93DD-49A0-8ACB-4B414F5DD439Q36469778-3458BEA0-D8DE-4F4A-A3E4-759F729133E3Q36510070-F9548EC1-C222-425F-8EF6-228ADFDE5F81Q36740722-1A0B2938-3169-48D5-96A9-55B320ADCF81Q36750166-70FBBACB-8AAE-4E6B-B2C0-71C750A48AFBQ36916354-1EE4DBFB-2C91-43F3-A14B-CD8C0299D07CQ37119791-00DAAFED-1C16-432D-A99C-F74870E68C8EQ37388657-C187F816-E16E-4DA2-AF90-8F6F481D8766
P2860
Expression of activated PIK3CA in ovarian surface epithelium results in hyperplasia but not tumor formation.
description
2009 nî lūn-bûn
@nan
2009 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
name
Expression of activated PIK3CA ...... lasia but not tumor formation.
@ast
Expression of activated PIK3CA ...... lasia but not tumor formation.
@en
type
label
Expression of activated PIK3CA ...... lasia but not tumor formation.
@ast
Expression of activated PIK3CA ...... lasia but not tumor formation.
@en
prefLabel
Expression of activated PIK3CA ...... lasia but not tumor formation.
@ast
Expression of activated PIK3CA ...... lasia but not tumor formation.
@en
P2093
P2860
P1433
P1476
Expression of activated PIK3CA ...... lasia but not tumor formation.
@en
P2093
Denise C Connolly
Dionyssios Katsaros
Katherine F Roby
Shun Liang
Thomas C Hamilton
Xiaojuan Lin
Xiaojun Yang
P2860
P356
10.1371/JOURNAL.PONE.0004295
P407
P577
2009-01-27T00:00:00Z